Abstract:Key PointsNMDA receptors (NMDARs) are ion channels gated by the excitatory neurotransmitter glutamate. NMDARs are widespread in the CNS and are essential mediators of synaptic transmission and plasticity.NMDARs exist as multiple subtypes that differ in their molecular (subunit) composition. There are assembled as tetramers composed of two obligatory GluN1 subunits along with two GluN2 or GluN3 subunits, of which there are four (GluN2A–GluN2D) and two subtypes (GluN3A and GluN3B) respectively.Each subunit has a typical modular architecture with two large clamshell-like extracellular domains (the N-terminal domain (NTD) involved in assembly and channel modulation and the agonist-binding domain (ABD)), a transmembrane domain (TMD) and a C-terminal domain (CTD) involved in receptor trafficking and signalling. The NTD and CTD regions are the most divergent and account for much of the functional diversity of NMDARs.Each subunit endows the receptor with distinct biophysical, pharmacological and signalling propertiesThe large extracellular region of the receptor harbours an array of binding sites for small-molecule ligands acting as endogenous or exogenous allosteric modulators. Several of these modulators display strong subunit-selectivity, thus allowing for pharmacological profiling of receptor subunit composition.NMDAR subunit composition is plastic, changing during development and according to neuronal activity. Long-term synaptic plasticity of NMDARs also occurs at mature (adult) synapses and has profound consequences on cell firing and subsequent plasticity.Whether specific receptor subtypes carry out specific tasks in the CNS remains a much debated and challenging issue. In particular, evidence points to tri-heteromeric GluN1/GluN2A/GluN2B receptors as critically involved in 'classical' LTP induction at adult CA3–CA1 synapses.NMDARs are implicated in various neurological and psychiatric conditions. Both hypo- and hyperfunction of NMDAR subpopulations can be deleterious, and there is vivid interest in targeting specific subunits for therapeutic interventions.

Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors

Integrins Regulate Nmda Receptor-Mediated Synaptic Currents

N-Glycosylation Regulates the Trafficking and Surface Mobility of GluN3A-Containing NMDA Receptors

Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors

Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists

Independent regulation of early trafficking of NMDA receptors by ligand-binding domains of the GluN1 and GluN2A subunits

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

Unmasking GluN1/GluN3A excitatory glycine NMDA receptors

Negative allosteric modulation of GluN1/GluN3 NMDA receptors

Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors

Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel

Conformational basis of subtype-specific allosteric control of NMDA receptor gating

Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors

GluN2A- and GluN2B-containing pre-synaptic N-methyl-d-aspartate receptors differentially regulate action potential-evoked Ca2+ influx via modulation of SK channels

A Novel Alcohol-Sensitive Position in the N-methyl-D-aspartate Receptor GluN2A Subunit M3 Domain Regulates Agonist Affinity and Ion Channel Gating.

Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors

Extrasynaptic NMDA Receptors Bidirectionally Modulate Intrinsic Excitability of Inhibitory Neurons

GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits

Computationally Discovered Potentiating Role of Glycans on NMDA Receptors

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease